In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Backed by its new products and pipeline drugs, AstraZeneca believes it can post industry-leading ... You can see the complete ...

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal ...

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

The negotiations lowered the price Medicare will pay for Merck's Januvia, Novo's Fiasp and AstraZeneca's Farxiga by a ...

That legislation, signed into law in 2022, includes provisions that aim to lower prescription drug costs for seniors, such as ...

AstraZeneca is holding crisis talks with the Chinese authorities after the arrest of its boss in the country. The ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...

The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...